Enovis

Enovis Gross Margin

The Gross Margin of Enovis (ENOV) as of Oct 26, 2026 is 59.84 %. In the previous year, Gross Margin was 56.02 % — a change of 6.82% (higher).

Gross Margin

59.84 %

YoY

6.82%

Last updated:

Gross Margin of Enovis is 2025 59.84 % . Gross Margin of Enovis was 2024 56.02 % . It decreases by 6.82% higher compared to the previous year.

Enovis's gross margin stands at 59.8%, up from 54.5% several years earlier.

The Enovis Gross Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Margin
Date
Gross Margin
Jan 1, 2018
33.26 USD
Jan 1, 2019
42.11 USD
Jan 1, 2020
41.95 USD
Jan 1, 2021
54.53 USD
Jan 1, 2022
55.62 USD
Jan 1, 2023
58.04 USD
Jan 1, 2024
56.02 USD
Jan 1, 2025
59.84 USD
The Enovis Gross Margin history
YEARGross MarginYoY
59.84 %+6.82%
56.02 %-3.47%
58.04 %+4.34%
55.62 %+2.00%
54.53 %+29.99%
41.95 %-0.38%
42.11 %+26.60%
33.26 %+6.62%
31.19 %-0.70%
31.41 %-0.45%
31.55 %-1.33%
31.98 %+10,200.00%
0.31 %+5.47%
0.29 %-14.99%
0.35 %-1.95%
0.35 %-0.20%
0.35 %-1.45%
0.36 %+3.54%
0.35 %-0.21%
0.35 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Enovis Stock analysis

What does Enovis do? Enovis Corp. generates revenue through its two business segments, Prevention & Recovery and Reconstructive. The Prevention & Recovery segment sells rigid bracing products, orthopedic soft goods, vascular systems, compression garments, and hot and cold therapy products to clinical rehabilitation and sports medicine markets, including recovery sciences products like bone growth stimulators and electrical stimulators for pain management. The Reconstructive segment focuses on knee, hip, shoulder, elbow, foot, ankle, and finger implant products, surgical productivity solutions, and Novastep, a minimally invasive surgery (MIS) foot and ankle solution, targeting healthcare providers and surgical centers. Medical device manufacturers and healthcare institutions are the primary buyers of these products, with the company's solutions addressing both preventive care and reconstructive procedures. The company's product portfolio includes clinically differentiated medical devices designed for specific applications in reconstructive surgery, rehabilitation, pain management, and physical therapy. By manufacturing and distributing these products under its own brand, Enovis Corp. serves healthcare providers seeking innovative solutions for patient recovery and surgical efficiency. The Prevention & Recovery segment's offerings, such as compression garments and therapy products, cater to both clinical and sports medicine applications, while the Reconstructive segment's implants and surgical tools are used in orthopedic procedures worldwide. The company's focus on minimally invasive solutions like Novastep enhances its appeal to surgeons and hospitals looking to reduce patient recovery times. Enovis Corp. targets healthcare providers, surgical centers, and rehabilitation facilities as key customers for its medical devices. The Prevention & Recovery segment's products, including bone growth stimulators and electrical stimulators, are sold to clinical rehabilitation and sports medicine markets, while the Reconstructive segment's knee, hip, and foot implant products are distributed to orthopedic surgical centers. The company's revenue streams are derived from direct sales of these branded medical devices, with no mention of third-party partnerships or external distribution channels in the business description. Enovis is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Enovis stock

Gross Margin of Enovis is 59.84 % in 2025.

Gross Margin of Enovis changed from 56.02 % to 59.84 %, representing a 6.82% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin Enovis since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's Enovis with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Enovis

All Key Metrics — Enovis